Status:
TERMINATED
FACBC Positron Emission Tomography/Computed Tomography(PET/CT) Used in the Diagnosis of Primary Prostate Cancer
Lead Sponsor:
David M. Schuster, MD
Conditions:
Prostate Cancers
Eligibility:
MALE
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this research project is to test if a compound (chemical substance) has a natural tendency to go to prostate cancer. This compound has a small amount of radioactivity attached to it and...
Eligibility Criteria
Inclusion
- Patients must be 18 years of age or older.
- Patients will be scheduled for prostatectomy based on a diagnosis of primary prostate cancer.
- Ability to lie still for PET scanning
- Patients must be able to provide written informed consent.
Exclusion
- Age less than 18
- Inability to lie still for PET scanning
- Cannot provide written informed consent.
- Less than 4 weeks since any prior prostate biopsy (to decrease false positive uptake from inflammation).
Key Trial Info
Start Date :
April 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2013
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT00917865
Start Date
April 1 2008
End Date
January 1 2013
Last Update
January 7 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Emory University Hospital
Atlanta, Georgia, United States, 30322